Cargando…
Surrogate indicators of sensitivity in gynecologic cytology: Can they be used to improve the measurement of sensitivity in the laboratory?
BACKGROUND: Measuring the sensitivity of screening in gynecologic cytology in real life is problematic. However, other quality measures may correlate with sensitivity, including the atypical squamous cells (ASC)/squamous intraepithelial lesion (SIL) ratio. Whether these other measures can function a...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762693/ https://www.ncbi.nlm.nih.gov/pubmed/19876383 http://dx.doi.org/10.4103/1742-6413.56359 |
_version_ | 1782172949121335296 |
---|---|
author | Renshaw, Andrew A Brimo, Fadi Auger, Manon |
author_facet | Renshaw, Andrew A Brimo, Fadi Auger, Manon |
author_sort | Renshaw, Andrew A |
collection | PubMed |
description | BACKGROUND: Measuring the sensitivity of screening in gynecologic cytology in real life is problematic. However, other quality measures may correlate with sensitivity, including the atypical squamous cells (ASC)/squamous intraepithelial lesion (SIL) ratio. Whether these other measures can function as “surrogate indicators” for sensitivity and improve the assessment of sensitivity in the laboratory is not known. MATERIALS AND METHODS: We compared multiple quality measures with true screening sensitivity in a variety of situations. RESULTS: The abnormal rate, ASC rate, and ASC/SIL ratio were all highly correlated (r =.83 or greater) with sensitivity when the overall laboratory sensitivity was low (85%) but became less correlated (.64 or less) or uncorrelated when the screening sensitivity was higher (88% or 95%, respectively). Sensitivity was more highly correlated with the abnormal rate than the ASC/SIL ratio at low screening sensitivity. While thresholds could be set that were highly sensitive and specific for suboptimal screening, these thresholds were often less than one standard deviation away from the mean. CONCLUSION: The correlation of the abnormal rate and the ASC/SIL ratio with sensitivity depends on overall sensitivity. Standards to define minimum screening sensitivity can be defined, but these standards are relatively narrow. These features may limit the utility of these quality measures as surrogates for sensitivity. |
format | Text |
id | pubmed-2762693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-27626932009-10-27 Surrogate indicators of sensitivity in gynecologic cytology: Can they be used to improve the measurement of sensitivity in the laboratory? Renshaw, Andrew A Brimo, Fadi Auger, Manon Cytojournal Original Article BACKGROUND: Measuring the sensitivity of screening in gynecologic cytology in real life is problematic. However, other quality measures may correlate with sensitivity, including the atypical squamous cells (ASC)/squamous intraepithelial lesion (SIL) ratio. Whether these other measures can function as “surrogate indicators” for sensitivity and improve the assessment of sensitivity in the laboratory is not known. MATERIALS AND METHODS: We compared multiple quality measures with true screening sensitivity in a variety of situations. RESULTS: The abnormal rate, ASC rate, and ASC/SIL ratio were all highly correlated (r =.83 or greater) with sensitivity when the overall laboratory sensitivity was low (85%) but became less correlated (.64 or less) or uncorrelated when the screening sensitivity was higher (88% or 95%, respectively). Sensitivity was more highly correlated with the abnormal rate than the ASC/SIL ratio at low screening sensitivity. While thresholds could be set that were highly sensitive and specific for suboptimal screening, these thresholds were often less than one standard deviation away from the mean. CONCLUSION: The correlation of the abnormal rate and the ASC/SIL ratio with sensitivity depends on overall sensitivity. Standards to define minimum screening sensitivity can be defined, but these standards are relatively narrow. These features may limit the utility of these quality measures as surrogates for sensitivity. Medknow Publications 2009-10-09 /pmc/articles/PMC2762693/ /pubmed/19876383 http://dx.doi.org/10.4103/1742-6413.56359 Text en © 2009 Renshaw et al; licensee Cytopathology Foundation Inc. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Renshaw, Andrew A Brimo, Fadi Auger, Manon Surrogate indicators of sensitivity in gynecologic cytology: Can they be used to improve the measurement of sensitivity in the laboratory? |
title | Surrogate indicators of sensitivity in gynecologic cytology: Can they be used to improve the measurement of sensitivity in the laboratory? |
title_full | Surrogate indicators of sensitivity in gynecologic cytology: Can they be used to improve the measurement of sensitivity in the laboratory? |
title_fullStr | Surrogate indicators of sensitivity in gynecologic cytology: Can they be used to improve the measurement of sensitivity in the laboratory? |
title_full_unstemmed | Surrogate indicators of sensitivity in gynecologic cytology: Can they be used to improve the measurement of sensitivity in the laboratory? |
title_short | Surrogate indicators of sensitivity in gynecologic cytology: Can they be used to improve the measurement of sensitivity in the laboratory? |
title_sort | surrogate indicators of sensitivity in gynecologic cytology: can they be used to improve the measurement of sensitivity in the laboratory? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762693/ https://www.ncbi.nlm.nih.gov/pubmed/19876383 http://dx.doi.org/10.4103/1742-6413.56359 |
work_keys_str_mv | AT renshawandrewa surrogateindicatorsofsensitivityingynecologiccytologycantheybeusedtoimprovethemeasurementofsensitivityinthelaboratory AT brimofadi surrogateindicatorsofsensitivityingynecologiccytologycantheybeusedtoimprovethemeasurementofsensitivityinthelaboratory AT augermanon surrogateindicatorsofsensitivityingynecologiccytologycantheybeusedtoimprovethemeasurementofsensitivityinthelaboratory |